New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma
Citation
Carlino, M, Kwan, V, Miller, D et al. 2015, 'New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma', Journal of Clinical Oncology, vol. 33, no. 11, pp. e52-e56.Year
2015ANU Authors
Fields of Research
- Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)
- Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)